Highlights from ASCO Gastrointestinal Cancers Symposium 2023
نویسندگان
چکیده
On January 19-21, 2023, approximately 4000 international gastrointestinal (GI) cancer specialists gathered in San Francisco for the ASCO Gastrointestinal Cancers Symposium to celebrate a 20-year milestone and discuss latest research treatment advances field. The multidisciplinary experts put science into context attendees were provided with truly comprehensive view of innovations GI oncology. current article highlights some most clinically relevant presentations from 2023 Symposium.
منابع مشابه
ASCO highlights podcast: head and neck cancers
A critical review of the head and neck cancer research highlights of the American Society of Clinical Oncology (ASCO) meeting 2016, held in June 2016 in Chicago, is presented in this podcast. Considering the most interesting and practice-changing trials reported at the meeting, the key trial comparing gemcitabine plus cisplatin against 5-FU (5-fluorouracil) plus cisplatin in the treatment of na...
متن کاملDiabetes and Pancreatic Cancer Highlights from the “ 2014 ASCO Gastrointestinal Cancers
Context Pancreatic cancer is the fourth leading cause of cancer mortality in the United States. Most of the patients are diagnosed in the metastatic staging. Consolidated risk factors include chronic pancreatitis, smoking and family history. Although controversial, diabetes mellitus has been increasingly associated with pancreatic cancer as a risk factor as opposed to just a manifestation of th...
متن کاملPalliative care from the beginning of treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Palliative care ought to be offered at the initiation of treatment for people who are diagnosed with pancreatic cancer, given the poor relative survival rate and the intractable symptom profile of those who have this life-limiting disease. In this article, we argue that palliative treatment of people with pancreatic cancer is not found in extending survival, but rather, in promoting quality of ...
متن کاملIdentification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Pancreatic cancer remains a significant cause of morbidity and mortality. While increasing treatment options have improved outcomes for many patients, they have also complicated decision-making for treatment. Unfortunately, most patients with pancreatic cancer die from their disease. Prognostic and predictive markers could play a role to improve treatment by identifying patients who may or may ...
متن کاملLocally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Although many cancers have seen a decline in rates due to screening techniques, the lack of viable screening for pancreatic cancer yields a large number of patients presenting with locally advanced and metastatic disease. Interesting new data regarding the management of locally advanced pancreatic cancer was presented at the 2010 ASCO Gastrointestinal Cancers Symposium, January 22-24, Orlando, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Medical & Radiation Oncology
سال: 2023
ISSN: ['2784-0131']
DOI: https://doi.org/10.53011/jmro.2023.01.04